Tight junction proteins in gastrointestinal and liver disease - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Gut Année : 2018

Tight junction proteins in gastrointestinal and liver disease

Résumé

Over the past two decades a growing body of evidence has demonstrated an important role of tight junction (TJ) proteins in the physiology and disease biology of GI and liver disease. On one side, TJ proteins exert their functional role as integral proteins of TJs in forming barriers in the gut and the liver. Furthermore, TJ proteins can also be expressed outside TJs where they play important functional roles in signalling, trafficking and regulation of gene expression. A hallmark of TJ proteins in disease biology is their functional role in epithelial-to-mesenchymal transition. A causative role of TJ proteins has been established in the pathogenesis of colorectal cancer and gastric cancer. Among the best characterised roles of TJ proteins in liver disease biology is their function as cell entry receptors for HCV-one of the most common causes of hepatocellular carcinoma. At the same time TJ proteins are emerging as targets for novel therapeutic approaches for GI and liver disease. Here we review our current knowledge of the role of TJ proteins in the pathogenesis of GI and liver disease biology and discuss their potential as therapeutic targets.
Fichier principal
Vignette du fichier
Zeisel, Dhawan and Baumert Gut 2018.pdf (592.74 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01910162 , version 1 (12-11-2018)

Identifiants

Citer

Mirjam B. Zeisel, Punita Dhawan, Thomas F. Baumert. Tight junction proteins in gastrointestinal and liver disease. Gut, 2018, Epub ahead of print. ⟨10.1136/gutjnl-2018-316906⟩. ⟨inserm-01910162⟩
352 Consultations
492 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More